Free Access
Med Sci (Paris)
Volume 25, Number 5, Mai 2009
Évaluation des risques et perspectives thérapeutiques en oncologie colorectale
Page(s) 467 - 472
Section M/S revues
Published online 15 May 2009
  1. Cullen BR. Transcription and processing of human microRNA precursors. Mol cell 2004; 16 : 861–5. [Google Scholar]
  2. Finoux AL, Chartrand P. Oncogenic and tumour suppressor microRNAs. Med Sci (Paris) 2008; 24 : 1049–54. [Google Scholar]
  3. Calin GA, Croce CM. Genomics of chronic lymphocytic leukemia microRNAs as new players with clinical significance. Sem in Oncol 2006; 33 : 167–73. [Google Scholar]
  4. Cimmino A, Calin GA, Fabbri M, et al. miR-15 and miR-16 induce apoptosis by targeting BCL2. Proc Natl Acad Sci USA 2005; 102 : 13944–9. [Google Scholar]
  5. Linsley PS, Schelter J, Burchard J, et al. Transcripts targeted by the microRNA-16 family cooperatively regulate cell cycle progression. Mol Cell Biol 2007; 27 : 2240–52. [Google Scholar]
  6. Lu J, Getz G, Miska EA, et al. MicroRNA expression profiles classify human cancers. Nature 2005; 435 : 834–8. [Google Scholar]
  7. Schickel R, Boyerinas B, Park SM, Peter ME. MicroRNAs : key players in the immune system, differentiation, tumorigenesis and cell death. Oncogene 2008; 27 : 5959–74. [Google Scholar]
  8. Liu CG, Calin GA, Meloon B, et al. An oligonucleotide microchip for genome-wide microRNA profiling in human and mouse tissues. Proc Natl Acad Sci USA 2004; 101 : 9740–4. [Google Scholar]
  9. Fabbri M, Garzon R, Andreeff M, Kantarjian HM, Garcia-Manero G, Calin GA. MicroRNAs and noncoding RNAs in hematological malignancies : molecular, clinical and therapeutic implications. Leukemia 2008; 22 : 1095–105. [Google Scholar]
  10. Ma L, Weinberg RA. Micromanagers of malignancy : role of microRNAs in regulating metastasis. Trends Genet 2008; 24 : 448–56. [Google Scholar]
  11. Nelson PT, Baldwin DA, Scearce LM, Oberholtzer JC, Tobias JW, Mourelatos Z. Microarray-based, high-throughput gene expression profiling of microRNAs. Nat Meth 2004; 1 : 155–61. [Google Scholar]
  12. Rebouissou S, Couchy G, Libbrecht L, et al. The beta-catenin pathway is activated in focal nodular hyperplasia but not in cirrhotic FNH-like nodules. J Hepatol 2008; 49 : 61–71. [Google Scholar]
  13. Bluteau O, Jeannot E, Bioulac-Sage P, et al. Bi-allelic inactivation of TCF1 in hepatic adenomas. Nat Genet 2002; 32 : 312–5. [Google Scholar]
  14. Chen YW, Jeng YM, Yeh SH, Chen PJ. P53 gene and Wnt signaling in benign neoplasms : beta-catenin mutations in hepatic adenoma but not in focal nodular hyperplasia. Hepatology 2002; 36 : 927–35. [Google Scholar]
  15. Zucman-Rossi J, Jeannot E, Nhieu JT, et al. Genotype-phenotype correlation in hepatocellular adenoma : new classification and relationship with HCC. Hepatology 2006; 43 : 515–24. [Google Scholar]
  16. Rebouissou S, Amessou M, Couchy G, et al. Frequent in-frame somatic deletions activate gp130 in inflammatory hepatocellular tumours. Nature 2008; 457 : 200–4. [Google Scholar]
  17. Zucman-Rossi J, Amessou M, Bioulac-Sage P, Rebouissou S. Gp130 activating mutations in inflammatory adenomas. Med Sci (Paris) 2008; 24 : 1113–4. [Google Scholar]
  18. Boyault S, Rickman DS, de Reynies A, et al. Transcriptome classification of HCC is related to gene alterations and to new therapeutic targets. Hepatology 2007; 45 : 42–52. [Google Scholar]
  19. Ladeiro Y, Couchy G, Balabaud C, et al. MicroRNA profiling in hepatocellular tumors is associated with clinical features and oncogene/tumor suppressor gene mutations. Hepatology (Baltimore, Md 2008; 47 : 1955–63. [Google Scholar]
  20. Jiang J, Gusev Y, Aderca I, et al. Association of MicroRNA expression in hepatocellular carcinomas with hepatitis infection, cirrhosis, and patient survival. Clin Cancer Res 2008; 14 : 419–27. [Google Scholar]
  21. Varnholt H, Drebber U, Schulze F, et al. MicroRNA gene expression profile of hepatitis C virus-associated hepatocellular carcinoma. Hepatology 2008; 47 : 1223–32. [Google Scholar]
  22. Murakami Y, Yasuda T, Saigo K, et al. Comprehensive analysis of microRNA expression patterns in hepatocellular carcinoma and non-tumorous tissues. Oncogene 2006; 25 : 2537–45. [Google Scholar]
  23. Kutay H, Bai S, Datta J, et al. Downregulation of miR-122 in the rodent and human hepatocellular carcinomas. J Cell Biochem 2006; 99 : 671–8. [Google Scholar]
  24. Meng F, Henson R, Wehbe-Janek H, Ghoshal K, Jacob ST, Patel T. MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer. Gastroenterology 2007; 133 : 647–58. [Google Scholar]
  25. Gramantieri L, Ferracin M, Fornari F, et al. Cyclin G1 is a target of miR-122a, a microRNA frequently down-regulated in human hepatocellular carcinoma. Cancer Res 2007; 67 : 6092–9. [Google Scholar]
  26. Huang YS, Dai Y, Yu XF, et al. Microarray analysis of microRNA expression in hepatocellular carcinoma and non-tumorous tissues without viral hepatitis. J Gastroenterol Hepatol 2008; 23 : 87–94. [Google Scholar]
  27. Wang Y, Lee AT, Ma JZ, et al. Profiling microRNA expression in hepatocellular carcinoma reveals microRNA-224 up-regulation and apoptosis inhibitor-5 as a microRNA-224-specific target. J Biol Chem 2008; 283 : 13205–15. [Google Scholar]
  28. Connolly E, Melegari M, Landgraf P, et al. Elevated expression of the miR-17-92 polycistron and miR-21 in hepadnavirus-associated hepatocellular carcinoma contributes to the malignant phenotype. Am J Pathol 2008; 173 : 856–64. [Google Scholar]
  29. Varnholt H. The role of microRNAs in primary liver cancer. Ann Hepatol 2008; 7 : 104–13. [Google Scholar]
  30. Girard M, Jacquemin E, Munnich A, Lyonnet S, Henrion-Caude A. miR-122, a paradigm for the role of microRNAs in the liver. J Hepatol 2008; 48 : 648–56. [Google Scholar]
  31. Jopling CL, Norman KL, Sarnow P. Positive and negative modulation of viral and cellular mRNAs by liver-specific microRNA miR-122. Cold Spring Harbor symposia on quantitative biology 2006; 71 : 369–76. [Google Scholar]
  32. Frankel LB, Christoffersen NR, Jacobsen A, Lindow M, Krogh A, Lund AH. Programmed cell death 4 (PDCD4) is an important functional target of the microRNA miR-21 in breast cancer cells. J Biol Chem 2008; 283 : 1026–33. [Google Scholar]
  33. Galardi S, Mercatelli N, Giorda E, et al. miR-221 and miR-222 expression affects the proliferation potential of human prostate carcinoma cell lines by targeting p27Kip1. J Biol Chem 2007; 282 : 23716–24. [Google Scholar]
  34. Liu WH, Yeh SH, Lu CC, et al. MicroRNA-18a prevents estrogen receptor-alpha expression, promoting proliferation of hepatocellular carcinoma cells. Gastroenterology 2009; 136 : 683–93 [Google Scholar]
  35. Budhu A, Jia HL, Forgues M, et al. Identification of metastasis-related microRNAs in hepatocellular carcinoma. Hepatology 2008; 47 : 897–907. [Google Scholar]
  36. Bousquet M, Dastugue N, Brousset P. MicroARN et translocations chromosomiques dans les hémopathies malignes. Med Sci 2009 (sous presse). [Google Scholar]
  37. Dunoyer P. La bataille du silence : mécanisme et inhibition du RNA silencing au cours des interactions plante/virus. Med Sci (Paris) 2009; 25 : 505–11. [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.